Stewart Fisher - Jul 29, 2021 Form 4 Insider Report for C4 Therapeutics, Inc. (CCCC)

Role
Chief Scientific Officer
Signature
/s/ Shoaib Ghias, Attorney-in-Fact
Stock symbol
CCCC
Transactions as of
Jul 29, 2021
Transactions value $
-$3,074,387
Form type
4
Date filed
8/2/2021, 06:46 PM
Next filing
Aug 5, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCCC Common Stock Sale -$2.26M -50.2K -46.44% $45.00* 57.9K Jul 29, 2021 Direct F1, F2
transaction CCCC Common Stock Sale -$815K -18.1K -31.27% $45.00* 39.8K Aug 2, 2021 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.085. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.07. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.